{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:13:36Z","timestamp":1793121216473,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-10388-y","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T01:50:46Z","timestamp":1736214646000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of bone mineral density and its influencing factors in patients infected with HIV under antiretroviral therapy"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3399-2360","authenticated-orcid":false,"given":"Alireza","family":"Azarboo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9305-6657","authenticated-orcid":false,"given":"Mahboobeh","family":"Hemmatabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6205-9794","authenticated-orcid":false,"given":"Noushin","family":"Fahimfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6225-3607","authenticated-orcid":false,"given":"Zahra","family":"Faghihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3210-7905","authenticated-orcid":false,"given":"SeyedAhmad","family":"SeyedAlinaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0731-9586","authenticated-orcid":false,"given":"Nooshin","family":"Shirzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4235-6969","authenticated-orcid":false,"given":"Ladan","family":"Abbasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"10388_CR1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S2352-4642(22)00219-X","volume":"6","author":"J Zhang","year":"2022","unstructured":"Zhang J, Ma B, Han X, Ding S, Li Y. Global, regional, and national burdens of HIV and other sexually transmitted infections in adolescents and young adults aged 10\u201324 years from 1990 to 2019: a trend analysis based on the global burden of Disease Study 2019. Lancet Child Adolesc Health. 2022;6:763\u201376.","journal-title":"Lancet Child Adolesc Health"},{"key":"10388_CR2","unstructured":"HIV data and statistics. [https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics]"},{"key":"10388_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2147\/CLEP.S37069","volume":"5","author":"SD Reid","year":"2013","unstructured":"Reid SD, Fidler SJ, Cooke GS. Tracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapy. Clin Epidemiol. 2013;5:387\u201396.","journal-title":"Clin Epidemiol"},{"key":"10388_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s40506-017-0109-9","volume":"9","author":"CA Moran","year":"2017","unstructured":"Moran CA, Weitzmann MN, Ofotokun I. Bone loss in HIV infection. Curr Treat Options Infect Dis. 2017;9:52\u201367.","journal-title":"Curr Treat Options Infect Dis"},{"key":"10388_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fendo.2015.00024","volume":"6","author":"A Zengin","year":"2015","unstructured":"Zengin A, Prentice A, Ward KA. Ethnic differences in bone health. Front Endocrinol (Lausanne). 2015;6:24.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10388_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30:3\u201344.","journal-title":"Osteoporos Int"},{"key":"10388_CR7","doi-asserted-by":"crossref","unstructured":"Mondockova V, Kovacova V, Zemanova N, Babikova M, Martiniakova M, Galbavy D, Omelka R. Vitamin D receptor gene polymorphisms affect osteoporosis-related traits and response to Antiresorptive Therapy. Genes (Basel) 2023, 14.","DOI":"10.3390\/genes14010193"},{"key":"10388_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/QAI.0000000000002958","volume":"90","author":"W Meng","year":"2022","unstructured":"Meng W, Chen M, Song Y, Zhang H, Xie R, Zhang F. Prevalence and risk factors of low bone Mineral Density in HIV\/AIDS patients: a Chinese cross-sectional study. J Acquir Immune Defic Syndr. 2022;90:360\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10388_CR9","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12879-021-06263-9","volume":"21","author":"P Atencio","year":"2021","unstructured":"Atencio P, Cabello A, Conesa-Buend\u00eda FM, P\u00e9rez-Tanoira R, Prieto-P\u00e9rez L, Carrillo I, \u00c1lvarez B, Arboiro-Pinel R, D\u00edaz-Curiel M, Herrero-Beaumont G, et al. Increased risk factors associated with lower BMD in antiretroviral-therapy\u2013na\u00efve HIV-infected adult male. BMC Infect Dis. 2021;21:542.","journal-title":"BMC Infect Dis"},{"key":"10388_CR10","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1086\/656412","volume":"51","author":"GA McComsey","year":"2010","unstructured":"McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, Huang JS, Aldrovandi GM, Cardoso SW, Santana JL, Brown TT. Bone disease in HIV infection: a practical review and recommendations for HIV Care Providers. Clin Infect Dis. 2010;51:937\u201346.","journal-title":"Clin Infect Dis"},{"key":"10388_CR11","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s00223-022-00946-4","volume":"110","author":"E Biver","year":"2022","unstructured":"Biver E. Osteoporosis and HIV infection. Calcif Tissue Int. 2022;110:624\u201340.","journal-title":"Calcif Tissue Int"},{"key":"10388_CR12","doi-asserted-by":"crossref","unstructured":"Ghaseminejad-Raeini A, Azarboo A, Zareshahi N, Jalali S, Fallahtafti P, Homaei A, Shirinezhad A, Hoveidaei AH. Early-life famine exposure and risk of osteoporosis and low bone mineral density: a systematic review and meta-analysis. Osteoporos Int 2024.","DOI":"10.1007\/s00198-024-07250-x"},{"key":"10388_CR13","doi-asserted-by":"crossref","unstructured":"Ndlovu SS, Ghazi T, Chuturgoon AA. The potential of Moringa oleifera to Ameliorate HAART-Induced Pathophysiological complications. Cells 2022, 11.","DOI":"10.3390\/cells11192981"},{"key":"10388_CR14","doi-asserted-by":"publisher","first-page":"e0164148","DOI":"10.1371\/journal.pone.0164148","volume":"11","author":"AR Means","year":"2016","unstructured":"Means AR, Risher KA, Ujeneza EL, Maposa I, Nondi J, Bellan SE. Impact of age and sex on CD4\u2009+\u2009cell count trajectories following treatment initiation: an analysis of the Tanzanian HIV Treatment Database. PLoS ONE. 2016;11:e0164148.","journal-title":"PLoS ONE"},{"key":"10388_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12981-017-0162-y","volume":"14","author":"MJ Kruger","year":"2017","unstructured":"Kruger MJ, Nell TA. Bone mineral density in people living with HIV: a narrative review of the literature. AIDS Res Therapy. 2017;14:35.","journal-title":"AIDS Res Therapy"},{"key":"10388_CR16","doi-asserted-by":"crossref","unstructured":"Survival. of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV 2017, 4:e349-e356.","DOI":"10.1016\/S2352-3018(17)30066-8"},{"key":"10388_CR17","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/jmv.21266","volume":"80","author":"D Gibellini","year":"2008","unstructured":"Gibellini D, De Crignis E, Ponti C, Cimatti L, Borderi M, Tschon M, Giardino R, Re MC. HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activation. J Med Virol. 2008;80:1507\u201314.","journal-title":"J Med Virol"},{"key":"10388_CR18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00198-017-4305-8","volume":"29","author":"SSL Goh","year":"2018","unstructured":"Goh SSL, Lai PSM, Tan ATB, Ponnampalavanar S. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors. Osteoporos Int. 2018;29:595\u2013613.","journal-title":"Osteoporos Int"},{"key":"10388_CR19","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1086\/656417","volume":"51","author":"HJ Stellbrink","year":"2010","unstructured":"Stellbrink HJ, Orkin C, Arribas JR, Compston J, Gerstoft J, Van Wijngaerden E, Lazzarin A, Rizzardini G, Sprenger HG, Lambert J, et al. Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study. Clin Infect Dis. 2010;51:963\u201372.","journal-title":"Clin Infect Dis"},{"key":"10388_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.292.2.191","volume":"292","author":"JE Gallant","year":"2004","unstructured":"Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD, Coakley DF, Lu B, Toole JJ, Cheng AK. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA. 2004;292:191\u2013201.","journal-title":"JAMA"},{"key":"10388_CR21","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1093\/infdis\/jir188","volume":"203","author":"GA McComsey","year":"2011","unstructured":"McComsey GA, Kitch D, Daar ES, Tierney C, Jahed NC, Tebas P, Myers L, Melbourne K, Ha B, Sax PE. Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids clinical trials Group A5224s, a substudy of ACTG A5202. J Infect Dis. 2011;203:1791\u2013801.","journal-title":"J Infect Dis"},{"key":"10388_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/QAD.0000000000002757","volume":"35","author":"S SeyedAlinaghi","year":"2021","unstructured":"SeyedAlinaghi S, Taj L, Mazaheri-Tehrani E, Ahsani-Nasab S, Abedinzadeh N, McFarland W, Mohraz M, Mirzazadeh A. HIV in Iran: onset, responses, and future directions. Aids. 2021;35:529\u201342.","journal-title":"Aids"},{"key":"10388_CR23","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1089\/aid.2014.0154","volume":"31","author":"L Camoni","year":"2015","unstructured":"Camoni L, Raimondo M, Dorrucci M, Regine V, Salfa MC, Suligoi B. Estimating minimum adult HIV prevalence: a cross-sectional study to assess the characteristics of people living with HIV in Italy. AIDS Res Hum Retroviruses. 2015;31:282\u20137.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10388_CR24","doi-asserted-by":"publisher","first-page":"e0227893","DOI":"10.1371\/journal.pone.0227893","volume":"15","author":"EM Chisati","year":"2020","unstructured":"Chisati EM, Constantinou D, Lampiao F. Reduced bone mineral density among HIV infected patients on anti-retroviral therapy in Blantyre, Malawi: prevalence and associated factors. PLoS ONE. 2020;15:e0227893.","journal-title":"PLoS ONE"},{"key":"10388_CR25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.drugpo.2010.04.006","volume":"21","author":"S Zamani","year":"2010","unstructured":"Zamani S, Radfar R, Nematollahi P, Fadaie R, Meshkati M, Mortazavi S, Sedaghat A, Ono-Kihara M, Kihara M. Prevalence of HIV\/HCV\/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran. Int J Drug Policy. 2010;21:493\u2013500.","journal-title":"Int J Drug Policy"},{"key":"10388_CR26","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s10461-014-0904-y","volume":"19","author":"M Malekinejad","year":"2015","unstructured":"Malekinejad M, Mohraz M, Razani N, Akbari G, McFarland W, Khairandish P, Malekafzali H, Gouya MM, Zarghami A, Rutherford GW. High HIV prevalence in a respondent-driven sampling survey of injection drug users in Tehran, Iran. AIDS Behav. 2015;19:440\u20139.","journal-title":"AIDS Behav"},{"key":"10388_CR27","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12903-021-01660-7","volume":"21","author":"S Shaghaghian","year":"2021","unstructured":"Shaghaghian S, Saranjam E, Homayooni M. Oral health-related quality of life in patients infected with HIV, Iran: a cross-sectional study. BMC Oral Health. 2021;21:308.","journal-title":"BMC Oral Health"},{"key":"10388_CR28","first-page":"460","volume":"49","author":"BM Badie","year":"2011","unstructured":"Badie BM, Soori T, Kheirandish P, Izadyar S, SeyedAlinagh S, Foroughi M, Rostamian A, Mohraz M. Evaluation of bone mineral density in Iranian HIV\/AIDS patients. Acta Med Iran. 2011;49:460\u20137.","journal-title":"Acta Med Iran"},{"key":"10388_CR29","unstructured":"Organisation WH. Scientific group on the assessment of osteoporosis at primary health care level. In: Summary Meeting Report. 2004. pp. 1\u201313."},{"key":"10388_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/1471-2334-12-192","volume":"12","author":"V Li Vecchi","year":"2012","unstructured":"Li Vecchi V, Soresi M, Giannitrapani L, Mazzola G, La Sala S, Tramuto F, Caruso G, Colomba C, Mansueto P, Madonia S, et al. Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected Mediterranean subjects. BMC Infect Dis. 2012;12:192.","journal-title":"BMC Infect Dis"},{"key":"10388_CR31","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1007\/s00198-013-2413-7","volume":"24","author":"JA Kanis","year":"2013","unstructured":"Kanis JA, Adachi JD, Cooper C, Clark P, Cummings SR, Diaz-Curiel M, Harvey N, Hiligsmann M, Papaioannou A, Pierroz DD, et al. Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF. Osteoporos Int. 2013;24:2763\u20134.","journal-title":"Osteoporos Int"},{"key":"10388_CR32","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.bjid.2020.05.008","volume":"24","author":"BMC Lara","year":"2020","unstructured":"Lara BMC, P\u00e1dua CM, Mendicino CCP, Rocha GM. Osteopenia and osteoporosis among treatment-experienced people living with HIV. Braz J Infect Dis. 2020;24:288\u201395.","journal-title":"Braz J Infect Dis"},{"key":"10388_CR33","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","volume":"20","author":"TT Brown","year":"2006","unstructured":"Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. Aids. 2006;20:2165\u201374.","journal-title":"Aids"},{"key":"10388_CR34","doi-asserted-by":"crossref","unstructured":"Soldado-Folgado J, Chillar\u00f3n JJ, Ca\u00f1as-Ruano E, Arrieta-Aldea I, Gonz\u00e1lez-Mena A, Blasco-Hernando F, Knobel H, Garcia-Giralt N. G\u00fcerri-Fern\u00e1ndez R: an abnormal inflammatory pattern Associated with Long-Term Non-progression of HIV infection impacts negatively on bone quality. J Clin Med 2022, 11.","DOI":"10.3390\/jcm11102927"},{"key":"10388_CR35","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s11904-022-00613-1","volume":"19","author":"AZ Olali","year":"2022","unstructured":"Olali AZ, Carpenter KA, Myers M, Sharma A, Yin MT, Al-Harthi L, Ross RD. Bone quality in relation to HIV and antiretroviral drugs. Curr HIV\/AIDS Rep. 2022;19:312\u201327.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10388_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00198-020-05584-w","volume":"32","author":"F Guo","year":"2021","unstructured":"Guo F, Song X, Li Y, Guan W, Pan W, Yu W, Li T, Hsieh E. Longitudinal change in bone mineral density among Chinese individuals with HIV after initiation of antiretroviral therapy. Osteoporos Int. 2021;32:321\u201332.","journal-title":"Osteoporos Int"},{"key":"10388_CR37","doi-asserted-by":"publisher","first-page":"e0230368","DOI":"10.1371\/journal.pone.0230368","volume":"15","author":"WM Han","year":"2020","unstructured":"Han WM, Wattanachanya L, Apornpong T, Jantrapakde J, Avihingsanon A, Kerr SJ, Teeratakulpisarn N, Jadwattanakul T, Chaiwatanarat T, Buranasupkajorn P, et al. Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: a five-year prospective study. PLoS ONE. 2020;15:e0230368.","journal-title":"PLoS ONE"},{"key":"10388_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11657-021-00903-y","volume":"16","author":"CJ Chang","year":"2021","unstructured":"Chang CJ, Chan YL, Pramukti I, Ko NY, Tai TW. People with HIV infection had lower bone mineral density and increased fracture risk: a meta-analysis. Arch Osteoporos. 2021;16:47.","journal-title":"Arch Osteoporos"},{"key":"10388_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12603-020-1452-y","volume":"25","author":"NF Lins Vieira","year":"2021","unstructured":"Lins Vieira NF, da Silva Nascimento J, do Nascimento CQ, Barros Neto JA. Oliveira Dos Santo ACS: Association between Bone Mineral Density and Nutritional Status, body composition and bone metabolism in older adults. J Nutr Health Aging. 2021;25:71\u20136.","journal-title":"J Nutr Health Aging"},{"key":"10388_CR40","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/hiv.13077","volume":"22","author":"NA Jespersen","year":"2021","unstructured":"Jespersen NA, Axelsen F, Dollerup J, N\u00f8rgaard M, Larsen CS. The burden of non-communicable diseases and mortality in people living with HIV (PLHIV) in the pre-, early- and late-HAART era. HIV Med. 2021;22:478\u201390.","journal-title":"HIV Med"},{"key":"10388_CR41","doi-asserted-by":"crossref","unstructured":"Emmanuelle NE, Marie-C\u00e9cile V, Florence T, Jean-Fran\u00e7ois A, Fran\u00e7oise L, Coralie F, Alexia V. Critical role of Estrogens on Bone Homeostasis in both male and female: from physiology to Medical implications. Int J Mol Sci 2021, 22.","DOI":"10.3390\/ijms22041568"},{"key":"10388_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1089\/aid.2018.0150","volume":"35","author":"PM Grant","year":"2019","unstructured":"Grant PM, Li X, Jacobson LP, Palella FJ Jr., Kingsley LA, Margolick JB, Dobs AS, Lake JE, Althoff KN, Brown TT. Effect of Testosterone Use on Bone Mineral density in HIV-Infected men. AIDS Res Hum Retroviruses. 2019;35:75\u201380.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10388_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/cid\/ciab874","volume":"75","author":"A Sharma","year":"2022","unstructured":"Sharma A, Hoover DR, Shi Q, Tien PC, Weber KM, Shah JG, Yin MT. Human immunodeficiency virus (HIV) and menopause are independently Associated with Lower Bone Mineral density: results from the women\u2019s interagency HIV Study. Clin Infect Dis. 2022;75:65\u201372.","journal-title":"Clin Infect Dis"},{"key":"10388_CR44","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jana.2015.03.005","volume":"26","author":"YI Cort\u00e9s","year":"2015","unstructured":"Cort\u00e9s YI, Yin MT, Reame NK. Bone density and fractures in HIV-infected Postmenopausal women: a systematic review. J Assoc Nurses AIDS Care. 2015;26:387\u201398.","journal-title":"J Assoc Nurses AIDS Care"},{"key":"10388_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4103\/tcmj.tcmj_177_19","volume":"33","author":"PK Gupta","year":"2021","unstructured":"Gupta PK, Singh S, Mahto SK, Sheoran A, Garga UC, Lal AK, Jain P, Mathews SE. Prevalence and predictors of low bone mineral density in treatment-naive HIV-infected patients and its correlation with CD4 cell counts. Tzu Chi Med J. 2021;33:49\u201354.","journal-title":"Tzu Chi Med J"},{"key":"10388_CR46","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/00002030-200104130-00022","volume":"15","author":"H Knobel","year":"2001","unstructured":"Knobel H, Guelar A, Vallecillo G, Nogu\u00e9s X, D\u00edez A. Osteopenia in HIV-infected patients: is it the disease or is it the treatment? Aids. 2001;15:807\u20138.","journal-title":"Aids"},{"key":"10388_CR47","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1097\/QAD.0000000000002001","volume":"32","author":"A Shaiykova","year":"2018","unstructured":"Shaiykova A, Pasquet A, Goujard C, Lion G, Durand E, Bayan T, Lach\u00e2tre M, Choisy P, Ajana F, Bourdic K, et al. Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated factors. Aids. 2018;32:2689\u201396.","journal-title":"Aids"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10388-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-10388-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10388-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T02:01:37Z","timestamp":1736215297000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-10388-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10388"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-10388-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Tehran University of Medical Sciences (IR.TUMS.MEDICINE.REC.1400.139) approved and verified the study protocol which was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"An informed consent signed by all the participants in the study was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}